What is also interesting is that Trace Genetics and Ellipsis are consistent revenue producers. Mentioned also by Karen is that although we lost revenue momentum in the last quarter from genotyping, there is another large project in the third quarter coming up.
One day you will finally come to the inevitable and depressing conclusion that you should never, ever, believe what one tells you, but only what that someone does for you. Really very simple concept for your kind consideration.
JMHO from 6 long years of DNAG doing absolutely nothing for the shareholders except destroy the value of their original investments.
News 
Market Data 
Discover 
AI
